1. EMA: suspend, recall Zinbryta following serious brain disorders

   News item 17 March 2018 Pages: 1 - 1

2. Medsafe: second idarucizumab dose may be required

   News item 17 March 2018 Pages: 2 - 2

3. In utero SSRI exposure delays elementary school start

   Clinical study 17 March 2018 Pages: 3 - 3

4. Calcium and colecalciferol increase risk of SSA/Ps

   Clinical study 17 March 2018 Pages: 4 - 4

5. CDC: opioid overdose epidemic in US continues to worsen

   Epidemiology clinical study 17 March 2018 Pages: 5 - 5

6. DHCPs are important source of new drug safety issues for HCPs

   Clinical study 17 March 2018 Pages: 6 - 6

7. Interest in mobile app for reporting ADRs

   Clinical study 17 March 2018 Pages: 7 - 7

8. Metformin use in PCOS pregnancy: risk of overweight chidren

   Clinical study 17 March 2018 Pages: 8 - 8

9. Metformin: childhood anthropometric parameters

   Clinical study 17 March 2018 Pages: 9 - 9

10. No link between vaccine antigen exposure and other infections

    Clinical study 17 March 2018 Pages: 10 - 10

11. Quadrivalent HPV vaccine: reports to VAERS

    Clinical study 17 March 2018 Pages: 11 - 11

12. Symmetry analysis screening confirms NOAC-related AEs

    Clinical study 17 March 2018 Pages: 12 - 12

13. Acenocoumarol

    Case report 17 March 2018 Pages: 13 - 13

14. Acitretin

    Case report 17 March 2018 Pages: 14 - 14

15. Adalimumab

    Case report 17 March 2018 Pages: 15 - 15

16. Adalimumab

    Case report 17 March 2018 Pages: 16 - 16

17. Adalimumab

    Case report 17 March 2018 Pages: 17 - 17

18. Adalimumab

    Case report 17 March 2018 Pages: 18 - 18

19. Adalimumab

    Case report 17 March 2018 Pages: 19 - 19

20. Adalimumab/etanercept

    Case report 17 March 2018 Pages: 20 - 20

21. Adalimumab/infliximab

    Case report 17 March 2018 Pages: 21 - 21

22. Adalimumab/methotrexate

    Case report 17 March 2018 Pages: 22 - 22

23. Adalimumab/sulfasalazine

    Case report 17 March 2018 Pages: 23 - 23

24. Afatinib

    Case report 17 March 2018 Pages: 24 - 24

25. Aflibercept/interferon-alpha

    Case report 17 March 2018 Pages: 25 - 25

26. Ajmaline

    Case report 17 March 2018 Pages: 26 - 26

27. Alcohol

    Case report 17 March 2018 Pages: 27 - 27

28. Alendronic acid/denosumab

    Case report 17 March 2018 Pages: 28 - 28

29. Alendronic acid/methotrexate

    Case report 17 March 2018 Pages: 29 - 29

30. Alendronic acid/pamidronic acid

    Case report 17 March 2018 Pages: 30 - 30

31. Alendronic-acid/zoledronic acid

    Case report 17 March 2018 Pages: 31 - 31

32. Allergy-immunotherapy/fire-ant-immunotherapy

    Case report 17 March 2018 Pages: 32 - 32

33. Allopurinol

    Case report 17 March 2018 Pages: 33 - 33

34. Alteplase

    Case report 17 March 2018 Pages: 34 - 34

35. Amiodarone

    Case report 17 March 2018 Pages: 35 - 35

36. Amiodarone

    Case report 17 March 2018 Pages: 36 - 36

37. Amiodarone

    Case report 17 March 2018 Pages: 37 - 37

38. Amitriptyline/chlorphenamine overdose

    Case report 17 March 2018 Pages: 38 - 38

39. Amlodipine/bisoprolol overdose

    Case report 17 March 2018 Pages: 39 - 39

40. Amoxicillin

    Case report 17 March 2018 Pages: 40 - 40

41. Amoxicillin/clavulanic acid

    Case report 17 March 2018 Pages: 41 - 41

42. Ampicillin

    Case report 17 March 2018 Pages: 42 - 42

43. Ampicillin

    Case report 17 March 2018 Pages: 43 - 43

44. Anaesthetics

    Case report 17 March 2018 Pages: 44 - 44

45. Anagrelide

    Case report 17 March 2018 Pages: 45 - 45

46. Anastrozole

    Case report 17 March 2018 Pages: 46 - 46

47. Anastrozole

    Case report 17 March 2018 Pages: 47 - 47

48. Antihypertensives/Class Ic antiarrhythmics

    Case report 17 March 2018 Pages: 48 - 48

49. Antineoplastics

    Case report 17 March 2018 Pages: 49 - 49

50. Antineoplastics

    Case report 17 March 2018 Pages: 50 - 50